U.S. Patents Awarded to Inventors in Virginia (Sept. 1)

Targeted News ServiceTargeted News Service

ALEXANDRIA, Va., Sept. 1 -- The following federal patents were awarded to inventors in Virginia.

***

Dogwood Pharmaceuticals Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Dogwood Pharmaceuticals, Charlottesville, Va., has been assigned a patent (8,252,767) developed by four co-inventors for a "substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine- -1-carboxylic acid esters as A.sub.2AR agonists." The co-inventors are Robert Thompson, Charlottesville, Va., Anthony Beauglehole, Charlottesville, Va., Frank Schmidtmann, Charlottesville, Va., and Jayson Rieger, Charlottesville, Va.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop- -2-ynyl}-piperidine-1-carboxylic acid esters and pharmaceutical compositions containing the same that are selective agonists of A.sub.2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents."

The patent application was filed on Dec. 20, 2008 (12/809,381). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,767&OS=8,252,767&RS=8,252,767

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Invention Science Fund I Assigned Patent for Methods, Compositions, and Kits for Collecting and Detecting Oligonucleotides

ALEXANDRIA, Va., Sept. 1 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,252,528) developed by eight co-inventors for "methods, compositions, and kits for collecting and detecting oligonucleotides." The co-inventors are Paul G. Allen, Seattle, Edward S. Boyden, Cambridge, Mass., Roderick A. Hyde, Redmond, Wash., Muriel Y. Ishikawa, Livermore, Calif., Stephen L. Malaska, Redmond, Wash., Dennis J. Rivet, Portsmouth, Va., Leif T. Stordal, Issaquah, Wash., and Lowell L. Wood Jr., Bellevue, Wash.The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods, pharmaceutical compositions, and kits are provided which includes accurately sampling a RNA from a tissue of an animal and analyzing RNA in the tissue of the animal as an indicator of physiological state, infectious disease, neoplastic disease, autoimmune disease, inflammatory disease, cardiovascular disease, atherosclerotic disease, or neurological disease in the animal. A method is provided which includes administering at least one compound to an animal wherein the at least one compound is configured to prevent the cleavage of at least one tissue RNA by a ribonuclease. The method further includes collecting a sample of at least a portion of tissue from the animal."

The patent application was filed on June 12, 2008 (12/157,984). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,528.PN.&OS=PN/8,252,528&RS=PN/8,252,528

Written by Kusum Sangma; edited by Anand Kumar.

***

Science Applications International Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Science Applications International, San Diego, has been Assigned a patent (8,252,969) developed by Edward Maxwell Yokley, Vienna, Va., and Ralph Bendt Nielsen, McLean, Va., for a "hypernucleophilic catalysts for detoxification of chemical threat agents."

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A polymeric hypernucleophilic catalyst is effective for hydrolytic destruction of chemical threat agents under mild conditions, e.g., near neutral pH and at ambient temperatures. The polymeric hypernucleophilic catalysts are particularly useful to affect rapid destruction of chemical threat agents on sensitive surfaces such as paint, metal, rubber, plastic, fabric, wood, and skin. Catalyst formulations such as creams, lotions, sprays, foams, powders, or gels, and articles such as filters, wipes, membranes, yarns, fabrics, and articles of clothing, may be used for detoxification of or prophylactic protection against chemical threat agents."

The patent application was filed on Sept. 4, 2007 (11/849,377). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,969&OS=8,252,969&RS=8,252,969

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Invention Science Fund I Assigned Patent for Methods for Collecting and Detecting Oligonucleotides

ALEXANDRIA, Va., Sept. 1 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,252,529) developed by eight co-inventors for "methods for collecting and detecting oligonucleotides." The co-inventors are Paul G. Allen, Seattle, Edward S. Boyden, Cambridge, Mass., Roderick A. Hyde, Redmond, Wash., Muriel Y. Ishikawa, Livermore, Calif., Stephen L. Malaska, Redmond, Wash., Dennis J. Rivet, Portsmouth, Va., Leif T. Stordal, Issaquah, Wash., and Lowell L. Wood Jr., Bellevue, Wash.The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods, pharmaceutical compositions, and kits are provided which includes accurately sampling a RNA from a tissue of an animal and analyzing RNA in the tissue of the animal as an indicator of physiological state, infectious disease, neoplastic disease, autoimmune disease, inflammatory disease, cardiovascular disease, atherosclerotic disease, or neurological disease in the animal. A method is provided which includes administering at least one compound to an animal wherein the at least one compound is configured to prevent the cleavage of at least one tissue RNA by a ribonuclease. The method further includes collecting a sample of at least a portion of tissue from the animal."

The patent application was filed on June 12, 2008 (12/157,985). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,529.PN.&OS=PN/8,252,529&RS=PN/8,252,529

Written by Kusum Sangma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1098434